Compound Detail
CHEMBL5426734
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5426734 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YAPDCHHXRQQJFW-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
413.5
MW (Da)
4.52
ALogP
4
HBA
1
HBD
67.5
PSA (Ų)
0.52
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.16
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| A549 | IC50 | = | 6890.0 | nM | 5.16 | Anticancer activity against human A549 cells assessed as inhibition in cell grow... | 37797804 |
| B16-F10 | IC50 | = | 15620.0 | nM | 4.81 | Anticancer activity against mouse B16-F10 cells assessed as inhibition in cell g... | 37797804 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37797804 | 10.1016/j.bmcl.2023.129494 | HCT-116 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | B16-F10 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | A549 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | SK-MEL-28 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | MCF7 | 1 |
| 37797804 | 10.1016/j.bmcl.2023.129494 | NRK-52E | 1 |
Data from ChEMBL 36 via Core Engine